News und Analysen
Granite Announces Renewal of Normal Course Issuer Bid
Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN / NYSE: GRP.U) (“Granite REIT” and “Granite GP”, and collectively, “Granite”) today announced the acceptance by the Toronto
GenSight Biologics Announces Publication of a Study of the Impact of LHON Disease on the Lives of Patients and Relatives in Journal of Neuro-Ophthalmology
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma Company focused on developing and commercializing innovative gene therapies for retinal
Lysogene Provides Clinical Update on AAVance Phase 2/3 Clinical Trial with Gene Therapy LYS-SAF302 for the Treatment of MPS IIIA at the 25th Annual ASGCT Meeting
Regulatory News:
Lysogene (FR0013233475 – LYS), a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, provided updated clinical data from the ongoing AAVance
Granite REIT Declares Distribution for May 2022
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2583 per stapled unit for the month of
MYHOTELMATCH: Authorisation of the Commercial Court to postpone the General Meeting
CI Global Asset Management Announces May 2022 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending May 31, 2022 in respect of the CI ETFs. In all cases, the distribution will be paid on
Mannatech Reports First Quarter End 2022 Financial Results
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2022.
DGAP-News: Befesa S.A.: Invitation to the Annual General Meeting on 16 June 2022
PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors
CI Financial Reports Financial Results for the First Quarter of 2022
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today released financial results for the quarter ended March 31, 2022.
“Achieving these strong results during a period of high economic and market
Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ)
CI Financial Releases Historical Results in New Segmentation Format
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today released quarterly 2021 data in accordance with its new segment reporting. In addition, CI has provided information about the accounting
DGAP-News: Medios AG: Revenue and earnings at record levels in the first quarter
Fuel Tech Reports 2022 First Quarter Financial Results
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and
CI Private Wealth to Establish Trust Company
CI Private Wealth US, LLC (“CIPW”), a subsidiary of CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX), announced today that it has applied for a charter to establish and operate a South Dakota trust
Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ)
CI Global Asset Management Announces Reinvested Distributions
CI Global Asset Management (CI GAM) announces the following reinvested distributions (the “Reinvested Distributions”) in respect of certain ETFs listed below. In all cases, these Reinvested
CI Global Asset Management Launches Blockchain and Metaverse ETFs
CI Global Asset Management (“CI GAM”) announces the launch of ETFs focused on investment opportunities in two digital megatrends transforming society today – blockchain technology and the
CI Financial Reports Total Assets of $369.8 Billion for March 2022
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today reported preliminary assets under management as at March 31, 2022 of $145.0 billion and wealth management assets of $224.7 billion, for total
CI Global Asset Management Announces Reinvested Distributions
CI Global Asset Management (CI GAM) announces the following reinvested distributions (the “Reinvested Distributions”) in respect of certain ETFs listed below. In all cases, these Reinvested
Fuel Tech Schedules 2022 First Quarter Financial Results and Conference Call
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and
DGAP-News: HelloFresh delivers close to €2bn of revenue in strong first quarter of 2022
DGAP-Adhoc: HelloFresh SE expects revenue and adjusted EBITDA ('AEBITDA') for Q1 2022 above market expectations
PAVmed to Hold a Business Update Conference Call on May 12, 2022
PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a highly differentiated, multi-product, commercial-stage medical device company today announced that the Company will host a business update conference call on